High bone density due to a mutation in LDL-receptor-related protein 5

New England Journal of Medicine

Volumn 346, Issue 20, 2002, Pages 1513-1521

  Boyden, Lynn M ^a   Mao, Junhao ^b   Belsky, Joseph ^a   Mitzner, Lyle ^a   Farhi, Anita ^a   Mitnick, Mary A ^a   Wu, Dianqing ^b   Insogna, Karl ^a   Lifton, Richard P ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBRONECTIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; OSTEOCALCIN; PROTEIN DICKKOPF 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BONE DENSITY; BONE MASS; BONE TURNOVER; CHROMOSOME 11Q; CHROMOSOME SEGREGATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; HUMAN CELL; MALE; MANDIBLE; NORRIE DISEASE; OSTEOLYSIS; OSTEOPOROSIS; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEGREGATION ANALYSIS; SIGNAL TRANSDUCTION;

BIOLOGICAL MARKERS; BONE DENSITY; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; GENES, DOMINANT; GENOTYPE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LDL-RECEPTOR RELATED PROTEINS; MALE; MANDIBLE; MUTATION, MISSENSE; OSTEOGENESIS; PALATE; PEDIGREE; POINT MUTATION; PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, LDL; SIGNAL TRANSDUCTION; SYNDROME; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0037118285     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa013444     Document Type: Article

References (40)

1. Diagnosis, and therapy, osteoporosis prevention, diagnosis, and therapy
2. Epidemiology and predictors of fractures associated with osteoporosis
3. Epidemiology of osteoporotic pelvic fractures in elderly people in Finland: Sharp increase in 1970-1997 and alarming projections for the new millennium
4. Incidence and costs to Medicare of fractures among Medicare beneficiaries aged ≥ 65 years - United States, July 1991-June 1992
5. Hip fracture
6. Determinants of reduced survival following hip fractures in men
7. Peak bone mass
8. Hyperostosis coticalis generalisata congenita
9. Idiopathic osteosclerosis: A report of 6 related cases
10. L'hyperostose corticale generalisee a transmission dominante (type Worth)
11. Van Buchem's disease (Hyperostosis corticalis generalisata)
12. Autosomal dominant osteosclerosis
13. Autosomal dominant osteosclerosis
14. Autosomal dominant endosteal hyperostosis: Report of a Spanish family with neurological involvement
15. Neurological involvement in Worth type endosteal hyperostosis: Report of a family
16. Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13)
17. Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13
18. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
19. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway
20. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6
21. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow
22. Increased circulating concentrations of parathyroid hormone in healthy, young women consuming a protein-restricted diet
23. Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy
24. Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteoperroses among the sclerosing bone disorders
25. Bone mineral density and laboratory evaluation of a type II autosomal dominant osteopetrosis carrier
26. Bone resorption by osteoclasts
27. Human autosomal recessive osteopetrosis maps to 11q13, a position predicted by comparative mapping of the murine osteosclerosis (oc) mutation
28. Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12-13
29. An extracellulax β-propeller module predicted in lipoprotein and scavenger receptors, tyrosine kinases, epidermal growth factor precursor, and extracellular matrix components
30. Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair
31. The Wnt/Wg signal transducer β-catenin controls fibronectin expression
32. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant highbone-mass trait
33. Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity
34. Estrogen modulates parathyroid hormone-induced fibronectin production in human and rat osteoblast-like cells
35. Parathyroid hormone increases circulating levels of fibronectin in vivo: Modulating effect of ovariectomy
36. Fibronectin is a survival factor for differentiated osteoblasts
37. Fibronectin regulates calvarial osteoblast differentiation
38. Comparison of the action of 17 beta-estradiol and progestins with insulin-like growth factors-I/-II and transforming growth factor-beta 1 on the growth of normal adult human bone-forming cells
39. Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblastenriched cultures from fetal rat bone
40. Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-betal gene